BG
CYTO

Bellevue Group’s Altamira Therapeutics Ltd CYTO Stock Holding History

Bellevue Group’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-24
Closed -$151K – 143
2018
Q2 		$151K Sell
24
-3
-11% -$31.7K 0.01% 138
2018
Q1 		$347K Hold
27
– – 0.03% 124
2017
Q4 		$1.28M Hold
27
– – 0.13% 99
2017
Q3 		$1.78M Hold
27
– – 0.19% 83
2017
Q2 		$1.55M Hold
27
– – 0.18% 91
2017
Q1 		$2M Hold
27
– – 0.27% 79
2016
Q4 		$2.32M Hold
27
– – 0.48% 56
2016
Q3 		$3.75M Hold
27
– – 0.68% 49
2016
Q2 		$9.09M Hold
27
– – 1.71% 17
2016
Q1 		$7.9M Buy
+27
New +$9.61M 1.43% 20

Other funds holding CYTO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return